FDA written feedback supports:- a single-arm, open-label registrational trial in 2nd-line refractory high-grade NMIBC with CIS- a randomized vs ...

A new clinical study published in the International Journal of Gynecological Cancer reports encouraging results for women ...

While online coaching improves asthma management short-term, it does not sustain physical activity changes, highlighting the ...

In a small pilot study of patients with advanced pancreatic cancer, early access to medical cannabis shows promise in the ...

Adding yoga to standard treatment for opioid use disorder is associated with faster recovery from opioid withdrawal symptoms.

Although a 2024 collab produced one of the best LEGO sets in recent memory, even the most hardcore fans may never complete ...

AM CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today ...

Revolution Medicines surged on AbbVie buyout rumors but pulled back after denial. Learn what's next for RVMD stock and why it ...

ORKA-002 interim Phase 1 data demonstrates a half-life of 75-80 days supporting potential for twice-per-year dosing in psoriasis and quarterly ...

On a preliminary unaudited basis, Krystal Biotech expects revenues of $388-$389M in 2025. The company ended the year with ...

Friday, Aurora Therapeutics debuted with $16 million in seed capital from Menlo Ventures. Its goal: To develop the industry’s ...